Dyne Therapeutics in Waltham, MA seeks a Principal Scientist of Oligonucleotide Development to lead the chemical synthesis strategy for PMO and modified ASO payloads, and to manage execution both internally and with CDMOs from preclinical development through GMP manufacture for IND‑enabling studies.
The role delivers robust, scalable, and cost‑effective processes, acts as the primary technical lead for external partners, shapes CMC strategy, supports regulatory filings, and contributes to global
#J-18808-LjbffrLead Oligonucleotide Development Scientist (PMO/ASO) in waltham at Unknown Company
This position is listed as full time and onsite.